Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems.
A series of simple methodologies for the determination of the redox status of low molecular weight and protein thiols in biological systems is described. Based centrally upon the use of monobromobimane, we describe a standard in situ derivatisation procedure simultaneously resulting in maximal recovery of both free, reduced low molecular weight and bromobimane accessible protein thiols as their corresponding bimane adducts from intact biological systems. Test systems include isolated and cultured cells, tissue homogenates and body fluids such as blood plasma. Quantitation of the bimane adducts of cysteine and glutathione is achieved by reversed phase high performance liquid chromatography, whereas quantitation of the corresponding adducts of protein thiols is achieved by fluorescence spectroscopy following protein precipitation. Full validation data for quantitative estimates are described. Additionally we have coupled these procedures to prederivatization denaturation treatments of biological protein samples in order to quantitate pools of protein thiols which are inaccessible to bromobimane in samples of native protein. We have also coupled these procedures with prederivatization reductions of biological systems under study with dithiothreitol, rendering simultaneously both oxidized low molecular weight thiols and oxidized protein thiols accessible to derivatisation with monobromobimane. Thus, we have obtained quantitative determinations of cysteine and glutathione present in mixed disulfides with protein and in soluble low molecular weight disulfides and estimates of intraprotein disulfides in a number of test biological systems.
D000818:Animals; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D002851:Chromatography, High Pressure Liquid; D003545:Cysteine / Q000032:analysis; D005978:Glutathione / Q000032:analysis; D006801:Humans; D008970:Molecular Weight; D010084:Oxidation-Reduction; D011506:Proteins / Q000032:analysis*; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013438:Sulfhydryl Compounds / Q000032:analysis*
D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D011506:Proteins; D013438:Sulfhydryl Compounds; D005978:Glutathione; D003545:Cysteine; C028381:monobromobimane